In Clinical Practice, Drug-Eluting Stents Outperform Bare-Metal Stents

Howard C. Herrmann

ScienceGate Book Chapters

JOURNAL ARTICLE

In Clinical Practice, Drug-Eluting Stents Outperform Bare-Metal Stents

Howard C. Herrmann

Year: 2007 Journal: Journal watch Vol: 2007 Publisher: Massachusetts Medical Society

Get Full-Text PDF Get Analytical Report

Abstract

Recent reports have raised concerns about late stent thrombosis with the use of drug-eluting stents (DES), particularly for off-label indications. In this National Heart, Lung, and Blood Institute Dynamic Registry analysis, investigators compared outcomes in 1763 patients who received at least one DES (for an on-label or off-label indication) …

Keywords:

Medicine Bare metal Drug Stent Clinical Practice Drug-eluting stent Internal medicine Cardiology Intensive care medicine Restenosis Pharmacology

Metrics

Cited By

0.00

FWCI (Field Weighted Citation Impact)

Refs

0.37

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Topics

Coronary Interventions and Diagnostics

Health Sciences → Medicine → Surgery

Antiplatelet Therapy and Cardiovascular Diseases

Health Sciences → Medicine → Cardiology and Cardiovascular Medicine

Cerebrovascular and Carotid Artery Diseases

Health Sciences → Medicine → Pulmonary and Respiratory Medicine

In Clinical Practice, Drug-Eluting Stents Outperform Bare-Metal Stents

Abstract

Metrics

Topics

Related Documents

Clinical trials: bare metal stents versus drug-eluting stents

Drug‐eluting stents versus bare metal stents

P6111First generation drug eluting stents outperform bare metal stents in 10-year survival

Cost-Effectiveness of Drug-Eluting Stents Versus Bare Metal Stents in Clinical Practice

Drug-eluting stents equivalent to bare metal stents?